Inactive Instrument
Quotes Celsion Corporation Nasdaq
Stocks
US15117N3052
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 24/09 | IMUNON, Inc. Presents Update On IMNN-001 Development Program For Women With Newly Diagnosed Advanced Ovarian Cancer | CI |
| 23/09 | Imunon, Inc. - Shareholder/Analyst Call |
Stock exchange
Basic data
Market Cap (USD)
56,39,460
Net sales (USD)
0
Free-Float
93.73%
Free-Float capitalization (USD)
52,85,650
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 56.39L | |
| +0.79% | -6.16% | +49.32% | +74.50% | 6.63TCr | |
| +0.16% | +6.66% | +11.82% | +90.60% | 5.29TCr | |
| -0.41% | +4.13% | +6.73% | +72.32% | 5.48TCr | |
| +0.74% | +2.75% | +26.31% | +45.29% | 4.41TCr | |
| +3.87% | +10.15% | +20.69% | +132.73% | 4.37TCr | |
| +7.91% | +4.30% | +263.91% | +602.72% | 4.21TCr | |
| -0.40% | +9.85% | +17.04% | +59.17% | 3.4TCr | |
| -1.30% | -0.68% | +37.15% | +7.04% | 2.62TCr | |
| +0.31% | +5.20% | +36.08% | +25.90% | 2.34TCr | |
| Average | +1.30% | +1.67% | +52.12% | +123.36% | 3.88TCr | |
| Weighted average by Cap. | +1.38% | +1.99% | +51.21% | +128.23% |
Historical Quotes: Celsion Corporation
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- IMNN Stock
- Stock
- Quotes Celsion Corporation
Select your edition
All financial news and data tailored to specific country editions
